| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea
|
Almeida, Camila Bononi
|
|
|
126 |
6 |
p. 711-720
|
article
|
| 2 |
A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy
|
Bonaud, Amélie
|
|
|
126 |
6 |
p. 757-765
|
article
|
| 3 |
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
|
Hagner, Patrick R.
|
|
|
126 |
6 |
p. 779-789
|
article
|
| 4 |
Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease
|
Detterich, Jon A.
|
|
|
126 |
6 |
p. 703-710
|
article
|
| 5 |
Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib
|
Patel, Keyur P.
|
|
|
126 |
6 |
p. 790-797
|
article
|
| 6 |
Early bone marrow involvement by mantle cell lymphoma
|
Clement, Parker W.
|
|
|
126 |
6 |
p. 825
|
article
|
| 7 |
Editorial Board
|
|
|
|
126 |
6 |
p. i
|
article
|
| 8 |
Evolution: IMiDs to PPMs, revolution in DLBCL?
|
Nowakowski, Grzegorz S.
|
|
|
126 |
6 |
p. 698-700
|
article
|
| 9 |
Horizontal RNA transfer mediates platelet-induced hepatocyte proliferation
|
Kirschbaum, Marc
|
|
|
126 |
6 |
p. 798-806
|
article
|
| 10 |
How I treat Waldenström macroglobulinemia
|
Treon, Steven P.
|
|
|
126 |
6 |
p. 721-732
|
article
|
| 11 |
Interleukin-6 in CLL: accelerator or brake?
|
Lapalombella, Rosa
|
|
|
126 |
6 |
p. 697-698
|
article
|
| 12 |
Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results
|
Wang, Michael L.
|
|
|
126 |
6 |
p. 739-745
|
article
|
| 13 |
Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A
|
Li, Yanmei
|
|
|
126 |
6 |
p. 766-778
|
article
|
| 14 |
Mouse prenatal platelet-forming lineages share a core transcriptional program but divergent dependence on MPL
|
Potts, Kathryn S.
|
|
|
126 |
6 |
p. 807-816
|
article
|
| 15 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia
|
Kim, Dae-Young
|
|
|
126 |
6 |
p. 746-756
|
article
|
| 16 |
Physiochemical artifacts in FeCl3 thrombosis models
|
Neeves, Keith B.
|
|
|
126 |
6 |
p. 700-701
|
article
|
| 17 |
Rasburicase-induced Heinz body hemolytic anemia in a patient with chronic lymphocytic leukemia
|
Hrisinko, Mary Ann
|
|
|
126 |
6 |
p. 826
|
article
|
| 18 |
Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach
|
Ciciliano, Jordan C.
|
|
|
126 |
6 |
p. 817-824
|
article
|
| 19 |
Revisiting the hyperhemolysis paradigm
|
Gladwin, Mark T.
|
|
|
126 |
6 |
p. 695-696
|
article
|
| 20 |
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12
|
Kuruvilla, John
|
|
|
126 |
6 |
p. 733-738
|
article
|
Journal description